BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29247460)

  • 1. Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.
    Rubaiy HN; Seitz T; Hahn S; Choidas A; Habenberger P; Klebl B; Dinkel K; Nussbaumer P; Waldmann H; Christmann M; Beech DJ
    Br J Pharmacol; 2018 Mar; 175(5):830-839. PubMed ID: 29247460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent, selective, and subunit-dependent activation of TRPC5 channels by a xanthine derivative.
    Minard A; Bauer CC; Chuntharpursat-Bon E; Pickles IB; Wright DJ; Ludlow MJ; Burnham MP; Warriner SL; Beech DJ; Muraki K; Bon RS
    Br J Pharmacol; 2019 Oct; 176(20):3924-3938. PubMed ID: 31277085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels.
    Rubaiy HN; Ludlow MJ; Siems K; Norman K; Foster R; Wolf D; Beutler JA; Beech DJ
    Br J Pharmacol; 2018 Aug; 175(16):3361-3368. PubMed ID: 29859013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Na
    Muraki K; Ohnishi K; Takezawa A; Suzuki H; Hatano N; Muraki Y; Hamzah N; Foster R; Waldmann H; Nussbaumer P; Christmann M; Bon RS; Beech DJ
    Sci Rep; 2017 Dec; 7(1):16988. PubMed ID: 29209034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Englerin A-evoked Cytotoxicity Is Mediated by Na+ Influx and Counteracted by Na+/K+-ATPase.
    Ludlow MJ; Gaunt HJ; Rubaiy HN; Musialowski KE; Blythe NM; Vasudev NS; Muraki K; Beech DJ
    J Biol Chem; 2017 Jan; 292(2):723-731. PubMed ID: 27875305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation.
    Carson C; Raman P; Tullai J; Xu L; Henault M; Thomas E; Yeola S; Lao J; McPate M; Verkuyl JM; Marsh G; Sarber J; Amaral A; Bailey S; Lubicka D; Pham H; Miranda N; Ding J; Tang HM; Ju H; Tranter P; Ji N; Krastel P; Jain RK; Schumacher AM; Loureiro JJ; George E; Berellini G; Ross NT; Bushell SM; Erdemli G; Solomon JM
    PLoS One; 2015; 10(6):e0127498. PubMed ID: 26098886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPC1 as a negative regulator for TRPC4 and TRPC5 channels.
    Kim J; Ko J; Myeong J; Kwak M; Hong C; So I
    Pflugers Arch; 2019 Aug; 471(8):1045-1053. PubMed ID: 31222490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and synthetic flavonoid modulation of TRPC5 channels.
    Naylor J; Minard A; Gaunt HJ; Amer MS; Wilson LA; Migliore M; Cheung SY; Rubaiy HN; Blythe NM; Musialowski KE; Ludlow MJ; Evans WD; Green BL; Yang H; You Y; Li J; Fishwick CW; Muraki K; Beech DJ; Bon RS
    Br J Pharmacol; 2016 Feb; 173(3):562-74. PubMed ID: 26565375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential PI(4,5)P
    Ko J; Myeong J; Shin YC; So I
    Sci Rep; 2019 Feb; 9(1):1849. PubMed ID: 30755645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Englerin A Inhibits T-Type Voltage-Gated Calcium Channels at Low Micromolar Concentrations.
    Wardas B; Schneider JG; Klugbauer N; Flockerzi V; Beck A
    Mol Pharmacol; 2023 Oct; 104(4):144-153. PubMed ID: 37399325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels.
    Akbulut Y; Gaunt HJ; Muraki K; Ludlow MJ; Amer MS; Bruns A; Vasudev NS; Radtke L; Willot M; Hahn S; Seitz T; Ziegler S; Christmann M; Beech DJ; Waldmann H
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3787-91. PubMed ID: 25707820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of a store-operated and 2-acetyl-sn-glycerol-sensitive non-selective cation channel. Heteromeric assembly of TRPC1-TRPC3.
    Liu X; Bandyopadhyay BC; Singh BB; Groschner K; Ambudkar IS
    J Biol Chem; 2005 Jun; 280(22):21600-6. PubMed ID: 15834157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous TRPC1, TRPC3, and TRPC7 proteins combine to form native store-operated channels in HEK-293 cells.
    Zagranichnaya TK; Wu X; Villereal ML
    J Biol Chem; 2005 Aug; 280(33):29559-69. PubMed ID: 15972814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.
    Cheung SY; Henrot M; Al-Saad M; Baumann M; Muller H; Unger A; Rubaiy HN; Mathar I; Dinkel K; Nussbaumer P; Klebl B; Freichel M; Rode B; Trainor S; Clapcote SJ; Christmann M; Waldmann H; Abbas SK; Beech DJ; Vasudev NS
    Oncotarget; 2018 Jul; 9(51):29634-29643. PubMed ID: 30038709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPC1 proteins confer PKC and phosphoinositol activation on native heteromeric TRPC1/C5 channels in vascular smooth muscle: comparative study of wild-type and TRPC1-/- mice.
    Shi J; Ju M; Abramowitz J; Large WA; Birnbaumer L; Albert AP
    FASEB J; 2012 Jan; 26(1):409-19. PubMed ID: 21968068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Englerin-A Has Analgesic and Anti-Inflammatory Effects Independent of TRPC4 and 5.
    de Sousa Valente J; Alawi KM; Bharde S; Zarban AA; Kodji X; Thapa D; Argunhan F; Barrett B; Nagy I; Brain SD
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Picomolar, selective, and subtype-specific small-molecule inhibition of TRPC1/4/5 channels.
    Rubaiy HN; Ludlow MJ; Henrot M; Gaunt HJ; Miteva K; Cheung SY; Tanahashi Y; Hamzah N; Musialowski KE; Blythe NM; Appleby HL; Bailey MA; McKeown L; Taylor R; Foster R; Waldmann H; Nussbaumer P; Christmann M; Bon RS; Muraki K; Beech DJ
    J Biol Chem; 2017 May; 292(20):8158-8173. PubMed ID: 28325835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPC4 and TRPC5: receptor-operated Ca2+-permeable nonselective cation channels.
    Plant TD; Schaefer M
    Cell Calcium; 2003; 33(5-6):441-50. PubMed ID: 12765689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype.
    Grant CV; Carver CM; Hastings SD; Ramachandran K; Muniswamy M; Risinger AL; Beutler JA; Mooberry SL
    Breast Cancer Res Treat; 2019 Sep; 177(2):345-355. PubMed ID: 31230251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction domains of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heteromultimeric channels.
    Myeong J; Ko J; Hong C; Yang D; Lee KP; Jeon JH; So I
    Biochem Biophys Res Commun; 2016 Jun; 474(3):476-481. PubMed ID: 27131740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.